What's Next from 10x Genomics

Michael Schnall-Levin has been at the company since its inception and today serves as Chief Technology Officer. Before joining 10x Genomics, Michael was a NSF postdoctoral fellow with Eric Lander at the Broad Institute, where he worked on developing novel applications of DNA sequencing technologies. Prior to that, Michael worked at Foundation Medicine, where he developed some of the early algorithms to accurately detect mutations in patient tumor samples. Michael earned his Ph.D in Mathematics from MIT with Bonnie Berger, where he was both a Hertz fellow and NDSEG fellow, and his B.A. in Physics from Harvard College.


Chromium Single Cell CNV provides a comprehensive, scalable solution for revealing genome heterogeneity and understanding clonal evolution. Study disease pathogenesis or characterize neuronal mosaicism at the single cell level.

Reveal Copy Number Variation, Cell by Cell

Single Cell CNV

Chromium

What's Next from 10x Genomics - AGBT 2018